NCT07218341 2026-02-10
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Eli Lilly and Company
Phase 4 Not yet recruiting
Clinical Trials
4 trialsNCT07024706 2026-01-21
MAVRiC
AstraZeneca
Phase 2 Not yet recruiting
NCT06979076 2025-09-29
A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL
MingSight Pharmaceuticals, Inc
Phase 1/2 Not yet recruiting
NCT05899543 2023-06-12
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
Power Life Sciences Inc.
Not yet recruiting